Yuhan Corp.
Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally. It also manufactures and sells animal feed and health functional food. The company was founded in 1926 and is headquartered in Seoul, South Korea.
Market Cap & Net Worth: Yuhan Corp. (000100)
Yuhan Corp. (KO:000100) has a market capitalization of $5.00 Billion (₩7.32 Trillion) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #3148 globally and #59 in its home market, demonstrating a 3.22% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yuhan Corp.'s stock price ₩99500.00 by its total outstanding shares 73615781 (73.62 Million).
Yuhan Corp. Market Cap History: 2015 to 2026
Yuhan Corp.'s market capitalization history from 2015 to 2026. Data shows growth from $1.76 Billion to $5.00 Billion (11.12% CAGR).
Yuhan Corp. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yuhan Corp.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Yuhan Corp.'s market cap is 0.00 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.08x
Yuhan Corp.'s market cap is 0.08 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.76 Billion | $1.13 Trillion | $126.05 Billion | 0.00x | 0.01x |
| 2016 | $1.36 Billion | $1.32 Trillion | $161.25 Billion | 0.00x | 0.01x |
| 2017 | $1.58 Billion | $1.46 Trillion | $109.03 Billion | 0.00x | 0.01x |
| 2018 | $1.57 Billion | $1.52 Trillion | $57.48 Billion | 0.00x | 0.03x |
| 2019 | $1.92 Billion | $1.48 Trillion | $40.01 Billion | 0.00x | 0.05x |
| 2020 | $3.22 Billion | $1.62 Trillion | $192.76 Billion | 0.00x | 0.02x |
| 2021 | $2.81 Billion | $1.69 Trillion | $102.58 Billion | 0.00x | 0.03x |
| 2022 | $2.74 Billion | $1.78 Trillion | $95.14 Billion | 0.00x | 0.03x |
| 2023 | $3.46 Billion | $1.86 Trillion | $136.20 Billion | 0.00x | 0.03x |
| 2024 | $6.01 Billion | $2.07 Trillion | $70.69 Billion | 0.00x | 0.08x |
Competitor Companies of 000100 by Market Capitalization
Companies near Yuhan Corp. in the global market cap rankings as of March 18, 2026.
Key companies related to Yuhan Corp. by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Yuhan Corp. Historical Marketcap From 2015 to 2026
Between 2015 and today, Yuhan Corp.'s market cap moved from $1.76 Billion to $ 5.00 Billion, with a yearly change of 11.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩5.00 Billion | -11.48% |
| 2025 | ₩5.65 Billion | -5.94% |
| 2024 | ₩6.01 Billion | +73.69% |
| 2023 | ₩3.46 Billion | +26.29% |
| 2022 | ₩2.74 Billion | -2.57% |
| 2021 | ₩2.81 Billion | -12.60% |
| 2020 | ₩3.22 Billion | +67.63% |
| 2019 | ₩1.92 Billion | +22.53% |
| 2018 | ₩1.57 Billion | -0.96% |
| 2017 | ₩1.58 Billion | +16.39% |
| 2016 | ₩1.36 Billion | -22.62% |
| 2015 | ₩1.76 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Yuhan Corp. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.00 Billion USD |
| MoneyControl | $5.00 Billion USD |
| MarketWatch | $5.00 Billion USD |
| marketcap.company | $5.00 Billion USD |
| Reuters | $5.00 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.